{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:54:30Z","timestamp":1780476870127,"version":"3.54.1"},"reference-count":12,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OVS"],"published-print":{"date-parts":[[2011,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose.<\/jats:title>\n                    <jats:p>Pemphigus vulgaris (PV) is an autoimmune blistering disease that affects mucous membranes and the skin. Most commonly, the disease begins in the oral cavity and spreads to other areas including the conjunctiva and eyelids. Ocular involvement is rare and likely underdiagnosed with a frequency that is underestimated. Ocular manifestations of systemic PV can imply severe disease and require a multidisciplinary approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Report.<\/jats:title>\n                    <jats:p>A 43\u2010year\u2010old black female presented with a chief complaint of pain with a white stringy discharge in the left eye for 2 weeks. On questioning, her health history revealed a 20\u2010year systemic history of PV. Assessment of the anterior segment revealed diffuse conjunctival hyperemia with an area of bulbar conjunctival erosion. Based on the constellation of history, signs, and symptoms, ocular PV was diagnosed precipitating treatment for the ocular lesions and referral to the dermatologist for control of the underlying systemic condition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>PV is an autoimmune disease of the pemphigus classification. It is characterized by the production of autoantibodies that attack intercellular substances. We review this unusual entity, its immunopathology, and treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/opx.0b013e31821ddef3","type":"journal-article","created":{"date-parts":[[2011,5,13]],"date-time":"2011-05-13T05:19:36Z","timestamp":1305263976000},"page":"1010-1013","source":"Crossref","is-referenced-by-count":12,"title":["Conjunctival Erosions Associated with Pemphigus Vulgaris"],"prefix":"10.1002","volume":"88","author":[{"given":"Rachel","family":"Brackley","sequence":"first","affiliation":[{"name":"The Eye Institute at Pennsylvania College of Optometry at Salus University Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marie","family":"Pagani","sequence":"additional","affiliation":[{"name":"The Eye Institute at Pennsylvania College of Optometry at Salus University Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,8,1]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.7861\/clinmedicine.9-4-371","article-title":"Pemphigus: a brief review","volume":"9","author":"Groves RW","year":"2009","journal-title":"Clin Med"},{"key":"e_1_2_5_3_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00004397-199703720-00006","article-title":"Ocular cicatricial pemphigoid and ocular manifestations of pemphigus vulgaris","volume":"37","author":"Smith RJ","year":"1997","journal-title":"Int Ophthalmol Clin"},{"key":"e_1_2_5_4_2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0190-9622(88)70128-0","article-title":"Pemphigus","volume":"18","author":"Korman N","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_5_5_2","first-page":"365","article-title":"Triamcinolone acetonide for rare ocular manifestations of pemphigus vulgaris: a case report","volume":"4","author":"Kozeis N","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jaad.2005.02.061","article-title":"Ocular pemphigus","volume":"53","author":"Daoud YJ","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_5_7_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/B:INTE.0000031736.69290.18","article-title":"Severe conjunctival and eyelid involvement in pemphigus vulgaris","volume":"25","author":"Lifshitz T","year":"2004","journal-title":"Int Ophthalmol"},{"key":"e_1_2_5_8_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ajo.2007.02.046","article-title":"Ocular involvement in pemphigus","volume":"144","author":"Palleschi GM","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2133.1990.tb01478.x","article-title":"Conjunctival involvement in pemphigus vulgaris: a clinical, histopathological and immunofluorescence study","volume":"123","author":"Hodak E","year":"1990","journal-title":"Br J Dermatol"},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1542\/peds.112.1.183","article-title":"Pemphigus vulgaris: the eyes have it","volume":"112","author":"Merchant S","year":"2003","journal-title":"Pediatrics"},{"key":"e_1_2_5_11_2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archderm.143.8.1033","article-title":"Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature","volume":"143","author":"Cianchini G","year":"2007","journal-title":"Arch Dermatol"},{"key":"e_1_2_5_12_2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly P","year":"2007","journal-title":"N Engl J Med"},{"key":"e_1_2_5_13_2","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0190-9622(96)90071-7","article-title":"Coexistence of pemphigus vulgaris and ocular cicatricial pemphigoid","volume":"34","author":"Buhac J","year":"1996","journal-title":"J Am Acad Dermatol"}],"container-title":["Optometry and Vision Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/OPX.0b013e31821ddef3","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1097\/OPX.0b013e31821ddef3","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/OPX.0b013e31821ddef3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:17:30Z","timestamp":1774937850000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/OPX.0b013e31821ddef3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.1097\/OPX.0b013e31821ddef3"],"URL":"https:\/\/doi.org\/10.1097\/opx.0b013e31821ddef3","archive":["Portico"],"relation":{},"ISSN":["1040-5488","1538-9235"],"issn-type":[{"value":"1040-5488","type":"print"},{"value":"1538-9235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}